Behavioral Health Business January 15, 2025
Substance use disorder (SUD) treatment providers who prescribe medications for opioid use disorder (MOUD) via telehealth received some good news on Wednesday.
The Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) announced a final rule that allows clinicians to prescribe buprenorphine via telehealth or audio-only telehealth visits for up to six months. This rule, called the Expansion of Buprenorphine Treatment via Telemedicine Encounter, is finalized and published in the Federal Register.
While the new rule could make it easier for virtual prescribing, many providers are worried that ambiguity in the regulations would complicate the legal landscape for MOUD prescribing in the future.
The DEA also released a proposed role that would allow certain practitioners to...
Today's Sponsors
Today's Sponsor